Effects of Bilobalide on Cerebral Amino Acid Neurotransmission

Bilobalide is one of many active constituents found in EGb 761® (definiton see editorial), which is extracted from Ginkgo biloba leaves. Whilst there is good, sound evidence that bilobalide exhibits neuroprotective actions in a variety of model systems, there is currently no consensus on its mechanism of action. This present communication summarises the results we have obtained with this compound on excitatory amino acid neurotransmission in the central nervous system using both neurochemical and electrophysiological techniques. Bilobalide was shown to reduce glutamate and aspartate release elicited by both high potassium-containing artificial cerebrospinal fluid (aCSF) or veratridine from mouse cortical slices. In addition, bilobalide had a very potent effect (IC₅₀ 2.7 μM) on glutamate release elicited by hypoxia/hypoglycaemia-induced release from rat cortical slices. Electrophysiologically, bilobalide also decreased the frequency of γ-aminobutyric acid (GABA) uptake inhibitor-induced depolarisations in mouse cortical slices, an effect probably mediated by a decrease in glutamate release. No definitive conclusions can be reached concerning the mechanism of action of bilobalide, but an ability to decrease excitotoxic amino acid release, particularly glutamate, would suggest that this is a probable mechanism to account for its neuroprotective properties.

References

• 1 Ahlemeyer B, Mowes A, Krieglstein J. Inhibition of serum deprivation- and stauropsorine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents.  Eur J Pharmacol. 1999;  367 423-430
• 2 Annels S J, Ellis Y, Davies J A. Non-opioid antitussives inhibit endogenous glutamate release from rabbit hippocampal slices.  Brain Res. 1991;  564 341-343
• 3 Bruno C, Cuppini R, Sartini S, Cecchini T, Ambrogini P, Bombardelli E. Regeneration of motor nerves in bilobalide treated rats.  Planta Med.. 1993;  59 302-307
• 4 Croucher M J, Collins J F, Meldrum B S. Anticonvulsant action of excitatory amino acid antagonists.  Science. 1982;  216 899-901
• 5 DeFeudis F V. Ginkgo biloba extract (Egb 761). 1998: 59-70 Ullstein Medical Wiesbaden;
• 6 DeFeudis F V. Ginkgo biloba extract (EGb 761). 1998 Ullstein Medical Wiesbaden;
• 7 Dickie B GM, Davies J A. Calcium blocking agents and potassium-stimulated release of glutamate from cerebellar slices.  Eur J Pharmacol. 1992;  229 97-99
• 8 Hu R Q, Davies J A. The effects of the desglycinyl metabolite of remacemide on cortical wedges prepared from DBA/2 mice.  Eur J Pharmacol. 1995;  287 251-256
• 9 Hu R Q, Davies J A. Tiagabine hydrochloride, an inhibitor of γ-aminobutyric acid (GAB A) uptake, induces cortical depolarizations in vitro.  Brain Res. 1997;  753 260-268
• 10 Janssens D, Michiels C, Delaive E, Eliars F, Drieu K, Remacle J. Protection of hypoxia-induced ATP decrease in endothelial cells by Ginkgo biloba extract and bilobalide.  Biochem Pharmacol. 1995;  50 991-999
• 11 Janssens D, Remacle J, Drieu K, Michiels C. Protection of mitochondrial respiration activity by bilobalide.  Biochem Pharmacol. 1999;  58 109-119
• 12 Jones F A, Davies J A. The anticonvulsant effects of the enantiomers of losigamone.  Br J Pharmacol. 1999;  128 1223-1228
• 13 Jones F A, Chatterjee S S, Davies J A. Effects of bilobalide on amino acid release and electrophysiology of cortical slices. Amino Acids 2002; In press
• 14 Klein J, Chatterjee S S, Loffelholz K. Phospholipid breakdown and choline release under hypoxic conditions: Inhibition by bilobalide, a constituent of Ginkgo biloba.  Brain Res. 1997;  755 347-350
• 15 Krieglstein J, Ahlemeyer F, El-Abhar H, Welsch M, Rupalla K, Henrich-Noack P. Neuroprotective effects of Ginkgo biloba constituents.  Eur J Pharmaceut Sei. 1995;  3 39-48
• 16 Nicholls D G, Attwell D. The release and uptake of excitatory amino acids.  Trends Pharmacol Sei. 1990;  11 462-468
• 17 Prehn J HM, Krieglstein J. Platelet-activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo.  J Neurosci Res. 1993;  34 179-188
• 18 Pietri S, Maurelli E, Drieu K, Culcasi M. Cardioprotective and anti-oxidant effect of the terpenoid constituents of Ginkgo biloba extract (EGb 761®).  J Mol Cell Cardiol. 1997;  29 733-742
• 19 Sasaki K, Hatta S, Haga M, Ohshika H. Effects of bilobalide on gamma-aminobutyric acid levels and glutamic acid decarboxylase in mouse brain.  Eur J Pharmacol. 1999;  367 165-173
• 20 Sasaki K, Hatta S, Wada K, Ohshika H, Haga M. Anticonvulsant activity of bilobalide, a sesquiterpine in Ginkgo biloba L. leaves, against chemical-induced and electroshock-induced convulsions in mice.  Res Commun Biol Psychiatry. 1995;  20 145-156
• 21 Sasaki K, Oota I, Wada I, Inomata K, Ohshika H, Haga M. Effects of bilobalide, a sesquiterpene in Ginkgo biloba leaves, on population spikes in rat hippocampal slices.  Comp Biochem Physiol. 1999;  124 315-321
• 22 Scholtyssek H, Damerau W, Wessel R, Schimke I. Antioxidative activity of ginkgolides against Superoxide in an aprotic environment.  Chem Biol Interact. 1997;  106 183-190
• 23 Srinivasan J, Richens A, Davies J A. The effect of the desglycinyl metabolite of remacemide hydrochloride (FPL 12495AA) and dizocilpine (MK-801) on endogenous amino acid release from mouse cortex.  Br J Pharmacol. 1995;  116 3087-3092
• 24 Turnell D C, Cooper J DH. Rapid assay for amino acids in serum or urine by pre-column derivatization and reverse-phase liquid chromatography.  Clin Chem. 1982;  28 527-531
• 25 Weichel O, Hilgert M, Chatterjee S S, Lehr M, Klein J. Bilobalide, a constituent of Ginkgo biloba inhibits NMDA-induced phospholipase A₂ activation and phospholipid breakdown in rat hippocampus. Naunyn-Schmeid.  Arch Pharmacol. 1999;  360 609-615
• 26 Zhou L J, Zhu X Z. Reactive oxygen species-induced apoptosis in PC 12 cells and protective effects of bilobalide.  J Pharmacol Exp Ther. 2000;  293 982-988